NDC product
ApexiCon E
NDC 10337-395 · PharmaDerm a division of Fougera Pharmaceuticals Inc.
Key facts
| Product NDC | 10337-395 |
|---|---|
| Proprietary name | ApexiCon E |
| Labeler | PharmaDerm a division of Fougera Pharmaceuticals Inc. |
| Marketing category | ANDA |
| Application number | ANDA076263 |
| Marketing start | Dec 20, 2002 |
| Marketing end | Apr 28, 2023 |
| Listing certified through | Apr 28, 2023 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: